IP Library Granted Patent US 9,034,367
Granted Patent B2
US 9,034,367 · App. 11/747,028 · Granted May 19, 2015

Articles for tissue regeneration with biodegradable polymer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,034,367
App. No.
11/747,028
Granted
May 19, 2015
Kind
B2
Abstract

The invention is to articles made from extracellular matrix sheets that encase biodegradable polymeric material. Methods of healing wounds or regenerating tissue at sites of defect by placing said articles in mammals are claimed. The biodegradable polymer can change quality upon contact with a physiological parameter such as temperature or pH that causes, for example, a liquid polymer to gel or harden. The degradation of the polymer can be controlled to suit a tissue regeneration or wound healing time course. Additional components such as proteins, cells and drugs can be added to the biopolymer composition.

Claims (12)

1. A tissue regeneration member, comprising:

an extracellular matrix (ECM) construct comprising a top member comprising a first sheet of first ECM comprising small intestine submucosa (SIS), said first sheet comprising first top and bottom surfaces, a bottom member comprising a second sheet of second ECM comprising liver basement membrane (LBM), said second sheet comprising second top and bottom surfaces, said first sheet first bottom surface and said second sheet second top surface being in communication with each other, wherein a construct space is formed therebetween, and a biodegradable composition disposed in said construct space, said biodegradable composition comprising an emulsion comprising poly ε-caprolactone and third ECM selected from the group consisting of LBM and urinary bladder submucosa (UBS).

2. The tissue regeneration member of claim 1 , wherein said ECM construct top member comprises a plurality of said first sheets of said first ECM.

3. The tissue regeneration member of claim 1 , wherein said ECM construct bottom member comprises a plurality of said second sheets of said second ECM.

4. A method comprising:

a) identifying a defect or wound in mammalian tissue in a mammal,

b)providing the tissue regeneration member of claim 1 ,

c) contacting said defect or wound with said tissue regeneration member, and

d) regenerating tissue at said defect or healing said wound.

5. The method of claim 4 , wherein said mammalian tissue is myocardial tissue.

6. The method of claim 4 , wherein said mammalian tissue is pancreatic tissue.

7. The method of claim 4 , wherein said mammalian tissue is liver tissue.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2025
From: CORMATRIX CARDIOVASCULAR, INC.
To: CORVIVO CARDIOVASCULAR, INC.
Reel/Frame 070481/0747 →
RELEASE OF SECURITY INTEREST Recorded Jun 2, 2017
From: MIDCAP FINANCIAL TRUST
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 042669/0559 →
SECURITY INTEREST Recorded Sep 30, 2015
From: CORMATRIX CARDIOVASCULAR, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 036732/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2009
From: MATHENY, ROBERT; LEWIS, BEECHER C.
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 022077/0947 →